This three-part webinar series will explore emerging substances, harm reduction and subsequent medical co-morbidities seen in WNC. Topics will include xylazine and other novel potent opioids, co-occurring diseases such as HCV, wound care,and harm reduction approaches.

Register online: www.mahec.net/events